| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 45 | 2024 | 997 | 10.530 |
Why?
|
| Tetrodotoxin | 28 | 2024 | 246 | 9.110 |
Why?
|
| Drug Delivery Systems | 58 | 2024 | 2226 | 8.970 |
Why?
|
| Nerve Block | 35 | 2024 | 706 | 7.290 |
Why?
|
| Anesthesia, Local | 21 | 2024 | 277 | 6.890 |
Why?
|
| Liposomes | 23 | 2024 | 783 | 6.340 |
Why?
|
| Bupivacaine | 28 | 2024 | 412 | 5.910 |
Why?
|
| Sciatic Nerve | 36 | 2024 | 617 | 5.470 |
Why?
|
| Delayed-Action Preparations | 27 | 2024 | 962 | 4.430 |
Why?
|
| Nanoparticles | 28 | 2024 | 1958 | 4.350 |
Why?
|
| Hydrogels | 21 | 2024 | 720 | 3.930 |
Why?
|
| Drug Carriers | 25 | 2024 | 706 | 3.800 |
Why?
|
| Biocompatible Materials | 35 | 2021 | 1685 | 3.670 |
Why?
|
| Hyaluronic Acid | 14 | 2015 | 483 | 3.200 |
Why?
|
| Polymers | 22 | 2024 | 1616 | 2.980 |
Why?
|
| Sodium Channel Blockers | 9 | 2023 | 173 | 2.740 |
Why?
|
| Nanomedicine | 10 | 2021 | 289 | 2.640 |
Why?
|
| Otitis Media | 5 | 2023 | 286 | 2.580 |
Why?
|
| Rats, Sprague-Dawley | 55 | 2023 | 8181 | 2.430 |
Why?
|
| Light | 13 | 2019 | 1353 | 2.230 |
Why?
|
| Gold | 10 | 2023 | 482 | 2.170 |
Why?
|
| Rats | 65 | 2024 | 23741 | 1.920 |
Why?
|
| Polyglycolic Acid | 13 | 2016 | 406 | 1.920 |
Why?
|
| Tympanic Membrane | 4 | 2023 | 232 | 1.760 |
Why?
|
| Contact Lenses | 7 | 2021 | 138 | 1.750 |
Why?
|
| Nanostructures | 7 | 2016 | 552 | 1.740 |
Why?
|
| Ciprofloxacin | 6 | 2018 | 312 | 1.690 |
Why?
|
| Infrared Rays | 6 | 2018 | 247 | 1.660 |
Why?
|
| Peritoneum | 7 | 2013 | 225 | 1.590 |
Why?
|
| Lactic Acid | 15 | 2016 | 1139 | 1.540 |
Why?
|
| Dexmedetomidine | 6 | 2018 | 319 | 1.490 |
Why?
|
| Animals | 141 | 2024 | 168475 | 1.470 |
Why?
|
| Ultrasonics | 4 | 2020 | 208 | 1.380 |
Why?
|
| Tissue Adhesions | 7 | 2013 | 218 | 1.380 |
Why?
|
| Peritoneal Diseases | 5 | 2007 | 75 | 1.340 |
Why?
|
| Cornea | 8 | 2022 | 1333 | 1.340 |
Why?
|
| Coated Materials, Biocompatible | 5 | 2016 | 311 | 1.310 |
Why?
|
| Prodrugs | 4 | 2024 | 261 | 1.280 |
Why?
|
| Nanotubes | 4 | 2018 | 82 | 1.270 |
Why?
|
| Materials Testing | 21 | 2017 | 863 | 1.250 |
Why?
|
| Hyperthermia, Induced | 3 | 2023 | 417 | 1.230 |
Why?
|
| Polyethylene Glycols | 8 | 2024 | 1189 | 1.230 |
Why?
|
| Anesthetics, Combined | 3 | 2018 | 43 | 1.220 |
Why?
|
| Metal Nanoparticles | 4 | 2014 | 399 | 1.210 |
Why?
|
| Cell Survival | 19 | 2020 | 5791 | 1.180 |
Why?
|
| Ultraviolet Rays | 8 | 2015 | 1080 | 1.160 |
Why?
|
| Microspheres | 14 | 2012 | 784 | 1.140 |
Why?
|
| Phototherapy | 4 | 2023 | 368 | 1.110 |
Why?
|
| Pharmaceutical Preparations | 5 | 2017 | 1089 | 1.080 |
Why?
|
| Tissue Adhesives | 3 | 2020 | 173 | 1.070 |
Why?
|
| Poloxamer | 3 | 2021 | 56 | 1.050 |
Why?
|
| Nanoshells | 2 | 2023 | 11 | 1.000 |
Why?
|
| Particle Size | 22 | 2017 | 1648 | 1.000 |
Why?
|
| Prostaglandins F, Synthetic | 2 | 2016 | 32 | 1.000 |
Why?
|
| Dexamethasone | 7 | 2021 | 1948 | 1.000 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2017 | 202 | 0.970 |
Why?
|
| Lipid Bilayers | 2 | 2023 | 383 | 0.950 |
Why?
|
| Nanocapsules | 2 | 2017 | 94 | 0.930 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2024 | 398 | 0.930 |
Why?
|
| Remote Sensing Technology | 3 | 2014 | 92 | 0.920 |
Why?
|
| Temperature | 7 | 2021 | 2226 | 0.910 |
Why?
|
| Technology, Pharmaceutical | 3 | 2014 | 84 | 0.890 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2018 | 507 | 0.880 |
Why?
|
| Photochemistry | 5 | 2013 | 239 | 0.870 |
Why?
|
| Polysorbates | 1 | 2023 | 44 | 0.860 |
Why?
|
| Polyesters | 5 | 2020 | 373 | 0.850 |
Why?
|
| Lidocaine | 6 | 2013 | 538 | 0.820 |
Why?
|
| Microscopy, Electron, Scanning | 15 | 2013 | 945 | 0.820 |
Why?
|
| Saxitoxin | 4 | 2015 | 65 | 0.820 |
Why?
|
| Adrenergic Agonists | 3 | 2017 | 58 | 0.800 |
Why?
|
| Anti-Bacterial Agents | 7 | 2023 | 7406 | 0.790 |
Why?
|
| Surface Properties | 8 | 2017 | 1161 | 0.790 |
Why?
|
| Tissue Engineering | 9 | 2013 | 1868 | 0.780 |
Why?
|
| Keratitis | 2 | 2022 | 241 | 0.780 |
Why?
|
| Polyethyleneimine | 2 | 2012 | 68 | 0.770 |
Why?
|
| Injections | 8 | 2024 | 831 | 0.770 |
Why?
|
| Capsaicin | 2 | 2019 | 231 | 0.770 |
Why?
|
| Rheology | 5 | 2021 | 347 | 0.770 |
Why?
|
| Drug Compounding | 6 | 2021 | 246 | 0.740 |
Why?
|
| Naloxone | 1 | 2023 | 370 | 0.730 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2022 | 64 | 0.730 |
Why?
|
| Caseins | 1 | 2021 | 104 | 0.720 |
Why?
|
| Magnetics | 4 | 2012 | 599 | 0.720 |
Why?
|
| Rhodamines | 1 | 2021 | 178 | 0.720 |
Why?
|
| Antifungal Agents | 3 | 2011 | 753 | 0.700 |
Why?
|
| Contact Lenses, Hydrophilic | 2 | 2011 | 54 | 0.690 |
Why?
|
| Microbubbles | 3 | 2024 | 135 | 0.680 |
Why?
|
| Tissue Scaffolds | 5 | 2014 | 934 | 0.670 |
Why?
|
| Photosensitizing Agents | 3 | 2019 | 623 | 0.650 |
Why?
|
| Excipients | 6 | 2021 | 98 | 0.650 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2016 | 421 | 0.650 |
Why?
|
| Chitosan | 7 | 2016 | 131 | 0.640 |
Why?
|
| Permeability | 6 | 2019 | 723 | 0.640 |
Why?
|
| Aptamers, Nucleotide | 2 | 2023 | 165 | 0.630 |
Why?
|
| Cross-Linking Reagents | 9 | 2012 | 687 | 0.620 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 366 | 0.620 |
Why?
|
| Barium Compounds | 1 | 2018 | 18 | 0.620 |
Why?
|
| Fluorescein | 3 | 2024 | 175 | 0.610 |
Why?
|
| Mice | 46 | 2024 | 81539 | 0.610 |
Why?
|
| Nanocomposites | 3 | 2014 | 49 | 0.610 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2018 | 58 | 0.600 |
Why?
|
| Dextrans | 3 | 2009 | 574 | 0.600 |
Why?
|
| Rabbits | 13 | 2021 | 4772 | 0.590 |
Why?
|
| Polylysine | 3 | 2019 | 131 | 0.580 |
Why?
|
| Titanium | 2 | 2018 | 485 | 0.580 |
Why?
|
| Candida albicans | 2 | 2011 | 372 | 0.580 |
Why?
|
| Cell Death | 5 | 2013 | 1679 | 0.580 |
Why?
|
| Epinephrine | 4 | 2017 | 792 | 0.560 |
Why?
|
| Inorganic Chemicals | 1 | 2016 | 10 | 0.560 |
Why?
|
| Glaucoma | 3 | 2016 | 1185 | 0.550 |
Why?
|
| Barbiturates | 1 | 2017 | 113 | 0.550 |
Why?
|
| Palladium | 1 | 2017 | 67 | 0.550 |
Why?
|
| Polymethacrylic Acids | 2 | 2008 | 32 | 0.550 |
Why?
|
| Tissue Distribution | 5 | 2019 | 2264 | 0.550 |
Why?
|
| Silicon Dioxide | 1 | 2017 | 216 | 0.550 |
Why?
|
| Gels | 4 | 2011 | 420 | 0.540 |
Why?
|
| Chinchilla | 4 | 2018 | 75 | 0.540 |
Why?
|
| Acrylic Resins | 2 | 2014 | 135 | 0.530 |
Why?
|
| Carbamazepine | 1 | 2017 | 224 | 0.530 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2013 | 803 | 0.530 |
Why?
|
| Clonidine | 2 | 2015 | 169 | 0.510 |
Why?
|
| Nanotechnology | 5 | 2013 | 714 | 0.510 |
Why?
|
| Intraocular Pressure | 3 | 2016 | 1294 | 0.500 |
Why?
|
| Radiation | 1 | 2015 | 49 | 0.500 |
Why?
|
| Choroidal Neovascularization | 1 | 2019 | 363 | 0.500 |
Why?
|
| Nanowires | 2 | 2012 | 31 | 0.490 |
Why?
|
| Sonication | 2 | 2018 | 79 | 0.480 |
Why?
|
| Cell Line | 13 | 2019 | 15601 | 0.480 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8527 | 0.480 |
Why?
|
| Alkanesulfonic Acids | 1 | 2017 | 201 | 0.470 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 91 | 0.470 |
Why?
|
| Propoxycaine | 1 | 2013 | 6 | 0.450 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 501 | 0.450 |
Why?
|
| Skin, Artificial | 1 | 2014 | 89 | 0.450 |
Why?
|
| Biofouling | 1 | 2013 | 8 | 0.450 |
Why?
|
| Electric Conductivity | 2 | 2011 | 405 | 0.440 |
Why?
|
| Elasticity | 4 | 2017 | 655 | 0.440 |
Why?
|
| Methylcellulose | 2 | 2010 | 34 | 0.440 |
Why?
|
| Molecular Weight | 5 | 2016 | 2186 | 0.440 |
Why?
|
| Equipment Design | 8 | 2016 | 3511 | 0.440 |
Why?
|
| Coma | 1 | 2017 | 484 | 0.430 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 647 | 0.430 |
Why?
|
| Pain | 3 | 2019 | 5073 | 0.430 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 94 | 0.430 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 730 | 0.420 |
Why?
|
| Immunomagnetic Separation | 1 | 2013 | 79 | 0.420 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2005 | 432 | 0.420 |
Why?
|
| Graphite | 1 | 2013 | 78 | 0.420 |
Why?
|
| Diffusion | 5 | 2017 | 814 | 0.410 |
Why?
|
| Electronics, Medical | 1 | 2012 | 72 | 0.410 |
Why?
|
| Administration, Topical | 4 | 2021 | 704 | 0.400 |
Why?
|
| Mice, Nude | 6 | 2021 | 3614 | 0.390 |
Why?
|
| Econazole | 1 | 2011 | 4 | 0.390 |
Why?
|
| Male | 60 | 2021 | 360846 | 0.390 |
Why?
|
| Blood Component Removal | 1 | 2013 | 132 | 0.390 |
Why?
|
| Oxides | 1 | 2013 | 401 | 0.390 |
Why?
|
| Acrylates | 3 | 2008 | 78 | 0.390 |
Why?
|
| Adrenergic Antagonists | 2 | 2001 | 26 | 0.380 |
Why?
|
| Solvents | 1 | 2012 | 295 | 0.380 |
Why?
|
| Synaptic Vesicles | 1 | 2013 | 190 | 0.380 |
Why?
|
| Deoxycytidine | 1 | 2016 | 877 | 0.380 |
Why?
|
| Cyanoacrylates | 1 | 2011 | 46 | 0.370 |
Why?
|
| Magnetite Nanoparticles | 1 | 2013 | 318 | 0.370 |
Why?
|
| Injections, Subcutaneous | 6 | 2012 | 681 | 0.360 |
Why?
|
| Gadolinium | 1 | 2016 | 960 | 0.360 |
Why?
|
| Polymerization | 3 | 2018 | 158 | 0.360 |
Why?
|
| Doxorubicin | 3 | 2024 | 2224 | 0.360 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 787 | 0.360 |
Why?
|
| Humans | 83 | 2024 | 761596 | 0.360 |
Why?
|
| Molecular Structure | 6 | 2020 | 1880 | 0.360 |
Why?
|
| Viscosity | 4 | 2021 | 336 | 0.350 |
Why?
|
| Keratinocytes | 1 | 2014 | 791 | 0.350 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2019 | 10766 | 0.350 |
Why?
|
| Microfluidics | 2 | 2013 | 653 | 0.350 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 532 | 0.350 |
Why?
|
| Durapatite | 1 | 2011 | 163 | 0.350 |
Why?
|
| Blood | 1 | 2013 | 596 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2019 | 3492 | 0.350 |
Why?
|
| Photochemical Processes | 3 | 2017 | 86 | 0.350 |
Why?
|
| Antibodies | 1 | 2018 | 2418 | 0.350 |
Why?
|
| Artificial Organs | 1 | 2011 | 150 | 0.350 |
Why?
|
| Sutures | 1 | 2012 | 284 | 0.340 |
Why?
|
| Phospholipids | 2 | 2023 | 786 | 0.340 |
Why?
|
| Cytokines | 3 | 2018 | 7396 | 0.340 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 150 | 0.330 |
Why?
|
| Collagen | 2 | 2015 | 2638 | 0.330 |
Why?
|
| Cells, Cultured | 14 | 2015 | 18966 | 0.320 |
Why?
|
| Skin Transplantation | 1 | 2014 | 1083 | 0.320 |
Why?
|
| Silicates | 1 | 2008 | 47 | 0.320 |
Why?
|
| Sensory Receptor Cells | 2 | 2012 | 513 | 0.310 |
Why?
|
| Time Factors | 19 | 2019 | 39969 | 0.310 |
Why?
|
| Micelles | 2 | 2019 | 192 | 0.310 |
Why?
|
| Sphingomyelins | 1 | 2008 | 105 | 0.310 |
Why?
|
| Ferritins | 1 | 2011 | 598 | 0.310 |
Why?
|
| Skin | 4 | 2024 | 4484 | 0.310 |
Why?
|
| Ceftazidime | 1 | 2008 | 57 | 0.310 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1726 | 0.310 |
Why?
|
| Mycotoxins | 1 | 2008 | 35 | 0.310 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 4 | 2004 | 41 | 0.300 |
Why?
|
| Acrylamides | 1 | 2009 | 260 | 0.290 |
Why?
|
| Fibroblasts | 4 | 2014 | 4142 | 0.290 |
Why?
|
| 3T3 Cells | 3 | 2021 | 1085 | 0.290 |
Why?
|
| Protons | 1 | 2013 | 1116 | 0.290 |
Why?
|
| Adhesiveness | 2 | 2021 | 52 | 0.280 |
Why?
|
| Neoplasms | 7 | 2020 | 22173 | 0.280 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2013 | 3769 | 0.280 |
Why?
|
| Ultrasonography | 3 | 2024 | 5971 | 0.280 |
Why?
|
| Cell Separation | 1 | 2013 | 1720 | 0.280 |
Why?
|
| Amphotericin B | 1 | 2007 | 142 | 0.280 |
Why?
|
| Candidiasis | 1 | 2009 | 365 | 0.280 |
Why?
|
| Wound Healing | 5 | 2020 | 2805 | 0.280 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2006 | 8 | 0.270 |
Why?
|
| Epithelium | 2 | 2008 | 1603 | 0.270 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2021 | 1541 | 0.270 |
Why?
|
| Cecal Diseases | 1 | 2006 | 49 | 0.270 |
Why?
|
| Cellulose | 1 | 2006 | 118 | 0.270 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 1141 | 0.270 |
Why?
|
| Dextran Sulfate | 3 | 2016 | 256 | 0.270 |
Why?
|
| Chemistry, Pharmaceutical | 6 | 2016 | 274 | 0.260 |
Why?
|
| Bone Transplantation | 1 | 2011 | 929 | 0.260 |
Why?
|
| Budesonide | 1 | 2007 | 157 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2012 | 1809 | 0.260 |
Why?
|
| Drug Implants | 3 | 2014 | 230 | 0.260 |
Why?
|
| Dopamine | 1 | 2013 | 1607 | 0.260 |
Why?
|
| Injections, Intravenous | 3 | 2018 | 1379 | 0.260 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 18255 | 0.260 |
Why?
|
| Neuralgia | 1 | 2012 | 615 | 0.260 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2048 | 0.250 |
Why?
|
| Myocytes, Cardiac | 3 | 2011 | 1668 | 0.250 |
Why?
|
| Flavoring Agents | 1 | 2005 | 53 | 0.250 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 840 | 0.250 |
Why?
|
| Cattle | 3 | 2018 | 3849 | 0.250 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 16990 | 0.240 |
Why?
|
| Injections, Intraperitoneal | 3 | 2013 | 413 | 0.240 |
Why?
|
| NIH 3T3 Cells | 4 | 2017 | 670 | 0.240 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 1457 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1651 | 0.240 |
Why?
|
| Implants, Experimental | 1 | 2005 | 99 | 0.240 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2004 | 57 | 0.240 |
Why?
|
| Surface Plasmon Resonance | 2 | 2017 | 269 | 0.240 |
Why?
|
| General Surgery | 2 | 2019 | 1692 | 0.240 |
Why?
|
| Prostheses and Implants | 1 | 2011 | 1271 | 0.240 |
Why?
|
| Peptides | 2 | 2014 | 4358 | 0.230 |
Why?
|
| Foreign-Body Reaction | 1 | 2005 | 157 | 0.230 |
Why?
|
| Chemokine CXCL12 | 3 | 2016 | 454 | 0.230 |
Why?
|
| Lactose | 2 | 2002 | 95 | 0.230 |
Why?
|
| Drug Synergism | 4 | 2018 | 1757 | 0.230 |
Why?
|
| Escherichia coli | 2 | 2013 | 4217 | 0.220 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 795 | 0.220 |
Why?
|
| Pain Threshold | 2 | 2018 | 604 | 0.220 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 13642 | 0.220 |
Why?
|
| Pyrroles | 1 | 2009 | 1125 | 0.210 |
Why?
|
| Forecasting | 1 | 2012 | 2928 | 0.210 |
Why?
|
| Muscimol | 1 | 2002 | 70 | 0.210 |
Why?
|
| Kinetics | 3 | 2018 | 6374 | 0.210 |
Why?
|
| Pheochromocytoma | 1 | 2005 | 328 | 0.210 |
Why?
|
| Solutions | 2 | 2016 | 412 | 0.200 |
Why?
|
| Sodium Channels | 2 | 2021 | 339 | 0.200 |
Why?
|
| Luminescence | 1 | 2022 | 108 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 1334 | 0.200 |
Why?
|
| Tetrazolium Salts | 2 | 2013 | 93 | 0.200 |
Why?
|
| Hot Temperature | 3 | 2005 | 1440 | 0.200 |
Why?
|
| Ultrasonic Therapy | 1 | 2024 | 215 | 0.200 |
Why?
|
| Models, Biological | 1 | 2018 | 9469 | 0.200 |
Why?
|
| Prenylation | 1 | 2021 | 37 | 0.190 |
Why?
|
| Pharmacokinetics | 2 | 2012 | 86 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 1036 | 0.190 |
Why?
|
| Photorefractive Keratectomy | 1 | 2021 | 38 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 983 | 0.190 |
Why?
|
| Alcohols | 1 | 2021 | 94 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 1164 | 0.190 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 317 | 0.190 |
Why?
|
| Carbon | 1 | 2005 | 666 | 0.190 |
Why?
|
| HeLa Cells | 4 | 2019 | 3094 | 0.190 |
Why?
|
| Histamine | 1 | 2023 | 499 | 0.180 |
Why?
|
| Serum Albumin | 2 | 2002 | 672 | 0.180 |
Why?
|
| Inflammation | 6 | 2023 | 10774 | 0.180 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2011 | 161 | 0.180 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 695 | 0.180 |
Why?
|
| Polyhydroxyethyl Methacrylate | 2 | 2011 | 30 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6345 | 0.180 |
Why?
|
| Chondroitin Sulfates | 2 | 2015 | 174 | 0.180 |
Why?
|
| Electrochemistry | 2 | 2010 | 145 | 0.170 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 1277 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 2496 | 0.170 |
Why?
|
| Boronic Acids | 1 | 2024 | 915 | 0.170 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15633 | 0.170 |
Why?
|
| Drug Stability | 2 | 2013 | 291 | 0.170 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 622 | 0.170 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 141 | 0.170 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 732 | 0.170 |
Why?
|
| Transcytosis | 1 | 2019 | 45 | 0.170 |
Why?
|
| Nanoconjugates | 1 | 2019 | 21 | 0.170 |
Why?
|
| Azepines | 1 | 2021 | 329 | 0.170 |
Why?
|
| Fluoroquinolones | 1 | 2021 | 307 | 0.170 |
Why?
|
| Phosphatidylethanolamines | 1 | 2019 | 129 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20100 | 0.160 |
Why?
|
| Proteins | 2 | 2012 | 6032 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2013 | 542 | 0.160 |
Why?
|
| Epilepsies, Partial | 1 | 2002 | 431 | 0.160 |
Why?
|
| Catalysis | 2 | 2021 | 774 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 2023 | 585 | 0.160 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2019 | 49 | 0.160 |
Why?
|
| Pseudomonas Vaccines | 1 | 2018 | 24 | 0.160 |
Why?
|
| Concanavalin A | 1 | 2018 | 190 | 0.160 |
Why?
|
| Xylazine | 1 | 2018 | 12 | 0.160 |
Why?
|
| Coumarins | 1 | 2019 | 118 | 0.160 |
Why?
|
| Amitriptyline | 2 | 2012 | 112 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2014 | 3429 | 0.150 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4853 | 0.150 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2018 | 125 | 0.150 |
Why?
|
| Albumins | 3 | 2008 | 575 | 0.150 |
Why?
|
| Peripheral Nerves | 1 | 2002 | 479 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2020 | 677 | 0.150 |
Why?
|
| Pentobarbital | 1 | 2018 | 153 | 0.150 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 18 | 0.140 |
Why?
|
| Myoblasts | 2 | 2009 | 231 | 0.140 |
Why?
|
| Macrophages | 3 | 2007 | 5767 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 6534 | 0.140 |
Why?
|
| Self Administration | 1 | 2018 | 390 | 0.140 |
Why?
|
| Swine | 3 | 2018 | 5915 | 0.140 |
Why?
|
| Photochemotherapy | 3 | 2019 | 823 | 0.140 |
Why?
|
| Decontamination | 1 | 2017 | 73 | 0.140 |
Why?
|
| Heating | 1 | 2017 | 104 | 0.140 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 4948 | 0.140 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 1668 | 0.140 |
Why?
|
| Water | 2 | 2013 | 1411 | 0.140 |
Why?
|
| Uveitis | 1 | 2020 | 395 | 0.140 |
Why?
|
| Adhesives | 1 | 2017 | 66 | 0.130 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2011 | 237 | 0.130 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 94 | 0.130 |
Why?
|
| Plasmapheresis | 1 | 2017 | 206 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6312 | 0.130 |
Why?
|
| Ear, Middle | 1 | 2018 | 339 | 0.130 |
Why?
|
| Haemophilus influenzae | 1 | 2016 | 178 | 0.130 |
Why?
|
| Female | 22 | 2022 | 392705 | 0.130 |
Why?
|
| Carbohydrate Conformation | 1 | 2015 | 206 | 0.130 |
Why?
|
| Tonometry, Ocular | 1 | 2016 | 235 | 0.130 |
Why?
|
| Corneal Diseases | 1 | 2021 | 542 | 0.130 |
Why?
|
| Anterior Eye Segment | 1 | 2016 | 143 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10451 | 0.130 |
Why?
|
| Cicatrix | 1 | 2021 | 798 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 1188 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 271 | 0.120 |
Why?
|
| Ruthenium Red | 1 | 2014 | 19 | 0.120 |
Why?
|
| Thiazoles | 2 | 2013 | 1517 | 0.120 |
Why?
|
| Carbocyanines | 1 | 2014 | 175 | 0.120 |
Why?
|
| Ophthalmic Solutions | 2 | 2021 | 313 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2016 | 903 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 847 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1349 | 0.110 |
Why?
|
| Nitro Compounds | 1 | 2013 | 74 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11904 | 0.110 |
Why?
|
| Catechols | 1 | 2013 | 62 | 0.110 |
Why?
|
| Benzopyrans | 1 | 2013 | 63 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2016 | 503 | 0.110 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 392 | 0.110 |
Why?
|
| Behavior, Animal | 4 | 2004 | 1878 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2014 | 1302 | 0.110 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2014 | 120 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2018 | 1154 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 172 | 0.100 |
Why?
|
| Injections, Intramuscular | 2 | 2005 | 554 | 0.100 |
Why?
|
| Physicians | 1 | 2011 | 4591 | 0.100 |
Why?
|
| Transistors, Electronic | 1 | 2012 | 22 | 0.100 |
Why?
|
| Biological Transport | 1 | 2017 | 2091 | 0.100 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2003 | 223 | 0.100 |
Why?
|
| Microtechnology | 1 | 2013 | 70 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2002 | 1906 | 0.100 |
Why?
|
| Oils | 1 | 2012 | 56 | 0.100 |
Why?
|
| Hemofiltration | 1 | 2013 | 59 | 0.100 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 321 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 999 | 0.100 |
Why?
|
| Emulsions | 1 | 2012 | 152 | 0.100 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 1039 | 0.100 |
Why?
|
| Toxicogenetics | 1 | 2012 | 20 | 0.100 |
Why?
|
| Ketamine | 1 | 2018 | 519 | 0.100 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2012 | 142 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 2024 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2019 | 64685 | 0.100 |
Why?
|
| Motor Neurons | 2 | 2012 | 870 | 0.100 |
Why?
|
| Heparin | 2 | 2016 | 1634 | 0.100 |
Why?
|
| Silk | 1 | 2012 | 90 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 1936 | 0.100 |
Why?
|
| Carbohydrates | 2 | 2005 | 390 | 0.100 |
Why?
|
| Motor Activity | 2 | 2017 | 2715 | 0.100 |
Why?
|
| Nitrilotriacetic Acid | 1 | 2011 | 8 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 794 | 0.100 |
Why?
|
| Administration, Inhalation | 3 | 2014 | 1157 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2161 | 0.100 |
Why?
|
| Calcium Channels, T-Type | 1 | 2011 | 28 | 0.100 |
Why?
|
| Electrophoresis | 1 | 2011 | 227 | 0.100 |
Why?
|
| Porosity | 2 | 2012 | 349 | 0.100 |
Why?
|
| Host vs Graft Reaction | 1 | 2011 | 13 | 0.100 |
Why?
|
| Hexuronic Acids | 1 | 2011 | 145 | 0.100 |
Why?
|
| Glucuronic Acid | 1 | 2011 | 150 | 0.100 |
Why?
|
| Optics and Photonics | 1 | 2013 | 306 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2012 | 211 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2014 | 582 | 0.100 |
Why?
|
| Neutrophils | 1 | 2024 | 3767 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2015 | 1791 | 0.100 |
Why?
|
| Static Electricity | 1 | 2012 | 261 | 0.100 |
Why?
|
| Desiccation | 1 | 2011 | 78 | 0.090 |
Why?
|
| Vaccines, Subunit | 2 | 2018 | 161 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2014 | 3088 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 685 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 409 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2016 | 1173 | 0.090 |
Why?
|
| Vaccines | 1 | 2020 | 844 | 0.090 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11461 | 0.090 |
Why?
|
| Photons | 1 | 2015 | 589 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 2645 | 0.090 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 143 | 0.090 |
Why?
|
| Shear Strength | 1 | 2011 | 160 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1229 | 0.090 |
Why?
|
| Platelet-Rich Plasma | 1 | 2013 | 178 | 0.090 |
Why?
|
| Polymethyl Methacrylate | 1 | 2011 | 131 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2012 | 544 | 0.090 |
Why?
|
| Histidine | 1 | 2011 | 308 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2206 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 624 | 0.090 |
Why?
|
| Epithelium, Corneal | 1 | 2013 | 253 | 0.090 |
Why?
|
| Arsenites | 1 | 1990 | 65 | 0.090 |
Why?
|
| Corneal Ulcer | 1 | 2011 | 128 | 0.090 |
Why?
|
| Nitrobenzenes | 1 | 2010 | 66 | 0.090 |
Why?
|
| Alginates | 1 | 2011 | 248 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 6214 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36426 | 0.090 |
Why?
|
| Hippocampus | 1 | 2002 | 3766 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2011 | 387 | 0.080 |
Why?
|
| Formaldehyde | 1 | 2011 | 358 | 0.080 |
Why?
|
| Silicon | 2 | 2012 | 142 | 0.080 |
Why?
|
| Hypertension | 2 | 2005 | 8540 | 0.080 |
Why?
|
| Colloids | 1 | 2009 | 123 | 0.080 |
Why?
|
| Estrogens | 1 | 2016 | 1522 | 0.080 |
Why?
|
| Oligopeptides | 2 | 2012 | 1187 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5872 | 0.080 |
Why?
|
| Estradiol | 1 | 2016 | 1937 | 0.080 |
Why?
|
| Sodium Chloride | 2 | 2007 | 587 | 0.080 |
Why?
|
| Anesthesiology | 1 | 2019 | 1120 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.080 |
Why?
|
| Survival | 1 | 2008 | 161 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 2386 | 0.080 |
Why?
|
| Acute Disease | 1 | 2019 | 7237 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 931 | 0.080 |
Why?
|
| Capsules | 2 | 2005 | 191 | 0.080 |
Why?
|
| Random Allocation | 1 | 2012 | 2395 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2012 | 1085 | 0.070 |
Why?
|
| Intracellular Space | 1 | 2009 | 197 | 0.070 |
Why?
|
| Career Choice | 1 | 2014 | 756 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1796 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2012 | 1492 | 0.070 |
Why?
|
| Bronchitis | 1 | 2008 | 196 | 0.070 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2008 | 139 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3808 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2010 | 562 | 0.070 |
Why?
|
| Absorbable Implants | 1 | 2009 | 338 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1014 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.070 |
Why?
|
| Metals | 1 | 2011 | 719 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2020 | 1251 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1505 | 0.070 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2006 | 201 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2007 | 195 | 0.070 |
Why?
|
| Gum Arabic | 1 | 2005 | 3 | 0.070 |
Why?
|
| Food Preservation | 1 | 2005 | 13 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3878 | 0.070 |
Why?
|
| Base Sequence | 2 | 2014 | 12441 | 0.060 |
Why?
|
| Benzoates | 1 | 2007 | 212 | 0.060 |
Why?
|
| Ligands | 1 | 2013 | 3272 | 0.060 |
Why?
|
| Sex Factors | 1 | 2019 | 10554 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 238 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2139 | 0.060 |
Why?
|
| Enuresis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Indoles | 1 | 2013 | 1833 | 0.060 |
Why?
|
| Sterilization | 1 | 2006 | 133 | 0.060 |
Why?
|
| Tyrosine | 1 | 2010 | 1440 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2006 | 1341 | 0.060 |
Why?
|
| Solubility | 1 | 2007 | 1091 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2010 | 1416 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 3847 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2008 | 2048 | 0.060 |
Why?
|
| Biomimetics | 1 | 2006 | 171 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2003 | 1903 | 0.060 |
Why?
|
| HIV Infections | 1 | 2011 | 17354 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2005 | 353 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 1990 | 1154 | 0.060 |
Why?
|
| Plant Oils | 1 | 2005 | 198 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2007 | 737 | 0.060 |
Why?
|
| Freezing | 1 | 2005 | 311 | 0.060 |
Why?
|
| Morpholines | 1 | 2007 | 581 | 0.060 |
Why?
|
| Catecholamines | 1 | 2005 | 386 | 0.060 |
Why?
|
| Lactalbumin | 1 | 2003 | 20 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 13446 | 0.060 |
Why?
|
| Gelatin | 1 | 2005 | 220 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2004 | 3551 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2009 | 653 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2006 | 750 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 437 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2019 | 4652 | 0.050 |
Why?
|
| Vasodilation | 1 | 2007 | 962 | 0.050 |
Why?
|
| Protein Binding | 1 | 2015 | 9353 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 2917 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1263 | 0.050 |
Why?
|
| Pilocarpine | 1 | 2002 | 64 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 2003 | 91 | 0.050 |
Why?
|
| Lipids | 2 | 2005 | 3341 | 0.050 |
Why?
|
| Peripheral Nervous System | 1 | 2024 | 151 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 858 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22174 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17635 | 0.050 |
Why?
|
| Energy Transfer | 1 | 2022 | 108 | 0.050 |
Why?
|
| Myometrium | 1 | 2003 | 174 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2005 | 419 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2015 | 740 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 1990 | 1403 | 0.050 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2002 | 86 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1578 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 225 | 0.050 |
Why?
|
| Sample Size | 1 | 2005 | 841 | 0.050 |
Why?
|
| Complement Activation | 1 | 2024 | 445 | 0.050 |
Why?
|
| Aorta | 1 | 1990 | 2041 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2006 | 522 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2115 | 0.050 |
Why?
|
| Acetone | 1 | 2021 | 44 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2012 | 5439 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1642 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2001 | 154 | 0.050 |
Why?
|
| Phentolamine | 1 | 2001 | 102 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2001 | 176 | 0.050 |
Why?
|
| Neurofibromatoses | 1 | 2005 | 299 | 0.050 |
Why?
|
| Aqueous Humor | 1 | 2021 | 153 | 0.050 |
Why?
|
| Lasers, Excimer | 1 | 2021 | 69 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2001 | 395 | 0.050 |
Why?
|
| Muscles | 1 | 2005 | 1576 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2007 | 807 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2021 | 273 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2006 | 1143 | 0.040 |
Why?
|
| Models, Animal | 1 | 2007 | 2112 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2021 | 404 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3889 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2001 | 293 | 0.040 |
Why?
|
| Amides | 2 | 2003 | 449 | 0.040 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 72 | 0.040 |
Why?
|
| Abdomen | 1 | 2006 | 1128 | 0.040 |
Why?
|
| Glycosides | 1 | 2020 | 100 | 0.040 |
Why?
|
| Tears | 1 | 2021 | 251 | 0.040 |
Why?
|
| Posterior Eye Segment | 1 | 2019 | 17 | 0.040 |
Why?
|
| Aging | 1 | 1998 | 8710 | 0.040 |
Why?
|
| Brain | 2 | 2005 | 27121 | 0.040 |
Why?
|
| Fluorescence | 1 | 2021 | 756 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1999 | 157 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2850 | 0.040 |
Why?
|
| Aerosols | 2 | 2013 | 635 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 152 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2000 | 498 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2004 | 1889 | 0.040 |
Why?
|
| Headache | 1 | 2005 | 1256 | 0.040 |
Why?
|
| Apnea | 1 | 1998 | 195 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2007 | 2009 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 477 | 0.030 |
Why?
|
| Cytosol | 1 | 2020 | 888 | 0.030 |
Why?
|
| Muramidase | 1 | 2016 | 169 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2017 | 330 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2018 | 616 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 2630 | 0.030 |
Why?
|
| Pyridines | 1 | 2007 | 2875 | 0.030 |
Why?
|
| Steroids | 1 | 2020 | 929 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2007 | 3028 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3677 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39106 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 343 | 0.030 |
Why?
|
| Nociceptors | 1 | 1998 | 461 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 654 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2016 | 592 | 0.030 |
Why?
|
| Drug Design | 1 | 2019 | 1048 | 0.030 |
Why?
|
| Monocrotaline | 1 | 2013 | 26 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6965 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2009 | 12794 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2019 | 1059 | 0.030 |
Why?
|
| Child | 2 | 2016 | 80158 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5485 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11530 | 0.030 |
Why?
|
| Neurons | 2 | 2002 | 9463 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2018 | 5870 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 244 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 912 | 0.030 |
Why?
|
| Lung | 3 | 2018 | 10002 | 0.020 |
Why?
|
| Vaccination | 1 | 2004 | 3384 | 0.020 |
Why?
|
| Ventilators, Mechanical | 1 | 2014 | 288 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2015 | 598 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 412 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 652 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1351 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3810 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1990 | 46 | 0.020 |
Why?
|
| Oxygen | 1 | 2001 | 4227 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12973 | 0.020 |
Why?
|
| Glucose | 1 | 2001 | 4347 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 7048 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 733 | 0.020 |
Why?
|
| Absorption | 1 | 2009 | 242 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 21019 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2088 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 88326 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1990 | 1545 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4937 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3530 | 0.020 |
Why?
|
| Retina | 1 | 2019 | 2659 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2001 | 3049 | 0.020 |
Why?
|
| Purinones | 1 | 2007 | 13 | 0.020 |
Why?
|
| Methionine | 1 | 1990 | 572 | 0.020 |
Why?
|
| Powders | 1 | 2007 | 80 | 0.020 |
Why?
|
| Respiration | 1 | 2014 | 1656 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2007 | 94 | 0.020 |
Why?
|
| Serum | 1 | 2009 | 209 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1990 | 897 | 0.020 |
Why?
|
| Angiotensin II | 1 | 1990 | 849 | 0.020 |
Why?
|
| Arsenic | 1 | 1990 | 362 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2007 | 205 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 214 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 395 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 795 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2467 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 239 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2820 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10090 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 170 | 0.020 |
Why?
|
| Apoptosis | 1 | 2001 | 9490 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2007 | 296 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6426 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2005 | 75 | 0.020 |
Why?
|
| Hydrazines | 1 | 2006 | 224 | 0.020 |
Why?
|
| Sheep | 1 | 2007 | 1440 | 0.010 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2004 | 100 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5205 | 0.010 |
Why?
|
| Spheroids, Cellular | 1 | 2006 | 330 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2019 | 5079 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2004 | 241 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4331 | 0.010 |
Why?
|
| Procaine | 1 | 2003 | 60 | 0.010 |
Why?
|
| Photography | 1 | 2006 | 532 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2006 | 636 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2112 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1971 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2014 | 2176 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2001 | 88 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2009 | 1732 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9280 | 0.010 |
Why?
|
| Calcium | 1 | 2014 | 5722 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6075 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2004 | 458 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2677 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 1351 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 9542 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2004 | 988 | 0.010 |
Why?
|
| RNA | 1 | 1990 | 2725 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 4016 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 1848 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2005 | 1113 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1674 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 1233 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26202 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2004 | 1528 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 6131 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 2136 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 1349 | 0.010 |
Why?
|
| Regeneration | 1 | 2006 | 1512 | 0.010 |
Why?
|
| Monocytes | 1 | 2004 | 2570 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2004 | 2747 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4431 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3549 | 0.010 |
Why?
|
| United States | 1 | 2019 | 72340 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2004 | 4580 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 16592 | 0.000 |
Why?
|
| Pregnancy | 1 | 2003 | 29890 | 0.000 |
Why?
|